News | Misonix press release

Misonix Enters Into Agreement to Acquire Regenerative Medical Company Solsys Medical

May 2, 2019

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC, a privately held regenerative medical company, to acquire Solsys in an all-stock transaction valued at approximately $97 million.

BRG Valuation Services provided a fairness opinion to the board of directors of Misonix in connection with the proposed transaction. 

Read the full press release.


Related Professionals

William Epstein

Managing Director

Los Angeles, Downtown, New York

Chau Hoang

Managing Director

New York